| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 56.9849 | 62 |
| GSM780708 | Untreated after 4 days (C2_1) | 52.2924 | 55 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.6202 | 39 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.1991 | 46 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.5262 | 30 |
| GSM780721 | Untreated after 4 days (C3_2) | 48.056 | 41 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.8751 | 51 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 47.3174 | 38 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 43.3914 | 19 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.3355 | 52 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 49.3162 | 46 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.0758 | 32 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.7231 | 51 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.7412 | 31 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.5083 | 39 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.1354 | 42 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.1283 | 42 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.735 | 48 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 47.0289 | 37 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.9324 | 48 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 50.1259 | 49 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.6473 | 30 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.7301 | 40 |